Tandem Diabetes Care (TNDM) Operating Income Growth (3y) (2016 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Operating Income Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 13.06% |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | 29.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.17% |
| Mar 31, 2026 | 48.52% |
| Dec 31, 2025 | 35.11% |
| Sep 30, 2025 | 21.63% |
| Jun 30, 2025 | -61.77% |
| Mar 31, 2025 | -99.00% |
| Dec 31, 2024 | -26.94% |
| Sep 30, 2024 | -75.22% |
| Jun 30, 2024 | -97.17% |
| Mar 31, 2024 | -134.38% |
| Dec 31, 2023 | -57.12% |
| Sep 30, 2023 | -215.03% |
| Jun 30, 2023 | -47.73% |
| Mar 31, 2023 | -111.17% |
| Dec 31, 2022 | -117.52% |
| Sep 30, 2022 | -99.25% |
| Jun 30, 2022 | -87.22% |
| Mar 31, 2022 | -11.73% |
| Dec 31, 2021 | 183.34% |
| Sep 30, 2021 | 35.57% |